CDER 2005 NME Approvals: Glass Half Full At Third Quarter Mark?
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA’s drug review center has approved just over half as many new molecular entities in the first three quarters of 2005 as it approved in the same time period of the preceding year.